NHS Framework Agreement for the supply of Direct Oral Anticoagulants (DOACs) for the NHS in England
Awarded by NHS England · 2021-07-22T16:54:09+01:00 · £3,185,000,000
Description
NHS Framework Agreement for the supply of Direct Oral Anticoagulants (DOACs) for the NHS in England. Also known as Novel Oral Anticoagulants (NOACs). Period of Framework: 01/11/2021 - 31/04/2024 with an option to extend (at the Authority's discretion) for a further period (or periods) up to a total of 12 months (i.e. total possible framework duration of 41 months) All documents can be found at https://health.atamis.co.uk/. Atamis Reference Number: C40079
- Buyer
- NHS England
- Value
- £3,185,000,000
- Category (CPV)
- Pharmaceutical products
- Award date
- 2021-07-22T16:54:09+01:00
Full CPV hierarchy, related awards from the same supplier and buyer, and any declared MP interest overlaps load below when JavaScript is enabled.